84 related articles for article (PubMed ID: 10982300)
1. Observer reliability in assessment of mitotic activity and MIB-1-determined proliferation rate in pediatric sarcomas.
Molenaar WM; Plaat BE; Berends ER; te Meerman GJ
Ann Diagn Pathol; 2000 Aug; 4(4):228-35. PubMed ID: 10982300
[TBL] [Abstract][Full Text] [Related]
2. Tumour cell proliferation rate as determined by MIB-1 antibody in Wilms' tumour.
Juszkiewicz P; Tuziak T; Zbisławski W; Liebhard M; Chosia M
Pol J Pathol; 1997; 48(2):113-9. PubMed ID: 9278108
[TBL] [Abstract][Full Text] [Related]
3. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
4. Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas.
Torp SH; Lindboe CF; Granli US; Moen TM; Nordtømme T
Clin Neuropathol; 2001; 20(5):190-5. PubMed ID: 11594503
[TBL] [Abstract][Full Text] [Related]
5. Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods.
Hsu CY; Ho DM; Yang CF; Chiang H
Mod Pathol; 2003 Sep; 16(9):951-7. PubMed ID: 13679460
[TBL] [Abstract][Full Text] [Related]
6. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
7. Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count.
Lehr HA; Hansen DA; Kussick S; Li M; Hwang H; Krummenauer F; Trouet S; Gown AM
Hum Pathol; 1999 Nov; 30(11):1314-20. PubMed ID: 10571511
[TBL] [Abstract][Full Text] [Related]
8. Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker.
Preusser M; Heinzl H; Gelpi E; Höftberger R; Fischer I; Pipp I; Milenkovic I; Wöhrer A; Popovici F; Wolfsberger S; Hainfellner JA
Histopathology; 2008 Jul; 53(1):39-47. PubMed ID: 18613924
[TBL] [Abstract][Full Text] [Related]
9. Interobserver variability in determining MIB-1 labeling indices in oligodendrogliomas.
Prayson RA; Castilla EA; Hembury TA; Liu W; Noga CM; Prok AL
Ann Diagn Pathol; 2003 Feb; 7(1):9-13. PubMed ID: 12616468
[TBL] [Abstract][Full Text] [Related]
10. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature.
Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM
Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855
[TBL] [Abstract][Full Text] [Related]
11. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas.
Kuhnen C; Herter P; Müller O; Muehlberger T; Krause L; Homann H; Steinau HU; Müller KM
Mod Pathol; 2000 Sep; 13(9):1005-13. PubMed ID: 11007041
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M
Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
[TBL] [Abstract][Full Text] [Related]
15. MIB-1 expression and iododeoxyuridine labelling in soft tissue sarcomas: an immunohistochemical study including correlations with p53, bcl-2 and histological characteristics.
Jensen V; Høyer M; Sørensen FB; Keller J; Jensen OM
Histopathology; 1996 May; 28(5):437-44. PubMed ID: 8735719
[TBL] [Abstract][Full Text] [Related]
16. The apoptotic paradox in retinoblastoma.
Sitorus RS; Gumay S; van der Valk P
Ann N Y Acad Sci; 2009 Aug; 1171():77-86. PubMed ID: 19723039
[TBL] [Abstract][Full Text] [Related]
17. Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count.
Weinstein MH
Hum Pathol; 2000 Apr; 31(4):520-1. PubMed ID: 10821503
[No Abstract] [Full Text] [Related]
18. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas.
Kim YJ; Ketter R; Steudel WI; Feiden W
Am J Clin Pathol; 2007 Jul; 128(1):118-25. PubMed ID: 17580279
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival.
Giuffrè G; Arena F; Scarfì R; Simone A; Todaro P; Tuccari G
Oncol Rep; 2006 Aug; 16(2):257-63. PubMed ID: 16820900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]